Abbott India Profile
Key Indicators
- Authorised Capital ₹ 27.50 Cr
- Paid Up Capital ₹ 21.25 Cr
- Company Age 80 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 10.80%
- Profit Growth 26.52%
- Ebitda 20.53%
- Net Worth 16.01%
- Total Assets 14.00%
About Abbott India
Abbott India Limited (AIL) was founded in India on 22 August 1944 and has a glorious history of 80 years and six months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 500488 and on the National Stock Exchange(NSE) under ABBOTINDIA.
The Corporate was formerly known as Boots Pure Drug Company (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 27.50 Cr and a paid-up capital of Rs 21.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Abbott India Limited India are Sridhar Kadangode as Cfo, Sangeeta Shetty as Company Secretary, and Venkateswaran Kadangode as Cfo. Munir Shaikh, Sudarshan Jain, Swati Dalal, and Five other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24239MH1944PLC007330
- Company No.
007330
- Stock Symbol
BSE : 500488 NSE : ABBOTINDIA
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Aug 1944
- Date of AGM
08 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does Abbott India Limited offer?
Abbott India Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets, Natural Therapy Services, Industrial Automation Systems, Automation Equipment, Medical Treatment Services, Cardiac Treatment Services, IT, Networking & Automation Solution, IT Solutions, Cancer Treatment.
Who are the key members and board of directors at Abbott India?
Executive Team (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Swati Dalal ![]() | Managing Director | 01-Apr-2024 | Current |
Sridhar Kadangode | CFO | 01-Jul-2023 | Current |
Sangeeta Shetty ![]() | Company Secretary | 14-Sep-2023 | Current |
Venkateswaran Kadangode | CFO | 12-Nov-2024 | Current |
Board Members (7)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sudarshan Jain ![]() | Director | 01-Apr-2019 | Current |
Shalini Kamath ![]() | Director | 29-Oct-2019 | Current |
Munir Shaikh ![]() | Director | 02-Mar-2001 | Current |
Kaiyomarz Marfatia ![]() | Director | 01-Mar-2011 | Current |
Anisha Motwani ![]() | Director | 25-Apr-2018 | Current |
Ambati Venu ![]() | Director | 29-Sep-2016 | Current |
Financial Performance of Abbott India.
Abbott India Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 10.8% increase. The company also saw a substantial improvement in profitability, with a 26.52% increase in profit. The company's net worth Soared by an impressive increase of 16.01%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Abbott India?
In 2024, Abbott India had a promoter holding of 74.99% and a public holding of 25.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Abbott India?
Abbott India has a workforce of 3696 employees as of Jan 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Abbott India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abbott India's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.